largest shareholder in Allergan Inc., and Valeant Pharmaceuticals said the botox maker's Chief Executive Officer David Pyott tried to discredit Valeant as it was making a hostile takeover bid, court documents showed.
BRK-A/B, DIS, GPS, JNJ, MCK, PAYX, PEP, PFE, PM, UNP ; pg 34]; Allergan [ AGN ; the CEO spotlight on David Pyott ; pg 36]. KO story http://online.barrons.com/article/SB50001424053111904742804579282313576005116.html
board members, including founder Gavin Herbert. Although these losses are unfortunate, we think Allergan, under CEO David Pyott 's leadership, continues to have a very talented and experienced management team and board. Pyott will assume Ball